Press Room

Filter by year:
July 14, 2020

[Video] Maximizing Your Digital Publishing Strategy: A Virtual Roundtable

GTxcel recently had the pleasure of hosting a virtual discussion panel for the City & Regional Magazine Association to discuss best practices for digital publishing. Sponsor City & Regional Magazine Association HostChris Collett, Director of Digital Strategy at GTxcel Co-Hosts Dan Fitek, Director of Product Development at GTxcelLeah Miranda, Senior Manager, Email Marketing at Campaign…

Read more
July 14, 2020

Predicting Reader Behavior with Publisher Analytics

Predicting changes in reader behavior is the key to a successful audience development strategy. Sudden shifts in audience behavior, like those caused by the recent COVID-19 pandemic, can be unpredictable, dramatic and affect all aspects of your publishing ecosystem. More predictable changes, such as those based on technology or infrastructure improvements, typically occur gradually and…

Read more
July 13, 2020

Should You Be Testing New Subscription Models?

Because digital subscriptions are flexible and can be quickly modified, there are always opportunities to test and innovate with different subscriber access models. For print-only subscriptions, the relationship between payment and access has always been straightforward: the customer provides payment (in the form of money or information), and your content gets delivered to them. In the…

Read more
July 13, 2020

Publishers Need Continuity During Print Channel Disruptions

When conventional distribution channels become disrupted, Turnstyle can provide continuity, delivering your content, and providing peace of mind. There’s little doubt that the COVID-19 pandemic has changed the digital publishing landscape. Supply chain disruptions and reduced ad spending have forced publishers to take a hard look at their short and long-term digital strategies. As the…

Read more
July 1, 2020

ProterixBio licenses COVID-19 serology test from Massachusetts General Hospital

Billerica, MA, July 1, 2020: ProterixBio, Inc. today announced completing a licensing agreement with the Massachusetts General Hospital for a COVID-19 serology assay. The assay was developed and validated by researchers at the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University which is a joint venture of Harvard University, Massachusetts…

Read more
June 25, 2020

Oppilan Pharma Announces Positive Phase 1 Data for its Ulcerative Colitis Drug OPL-002 at Digestive Disease Week 2020 Virtual Scientific Program

Potential best-in-class profile for an oral sphingosine-1-phosphate receptor modulator – Dose-dependent reduction in circulating lymphocytes –– Rapid lymphocyte recovery after cessation of dosing –– Phase 2 study in ulcerative colitis patients in 4Q 2020 – ENCINITAS, California and Cambridge, United Kingdom, June 23, 2020 – Oppilan Pharma, Ltd., a clinical-stage biopharmaceutical company focused on developing…

Read more
April 16, 2020

As the Global Crisis Evolves, Publishers are Focusing on Digital with a Renewed Sense of Urgency

By understanding their platform’s capabilities and following best practices, publishers can be confident in their digital strategy during these uncertain times. There’s little doubt that the COVID-19 pandemic has changed the digital publishing landscape. Supply chain disruptions and reduced ad spending are forcing publishers to take a hard look at their short and long-term digital…

Read more
March 5, 2020

Perceptimed Awarded NIH Development Grant

PERCEPTIMED AWARDED $1.5M NIH DEVELOPMENT GRANT   MOUNTAIN VIEW, CA – PerceptiMed, Inc., was awarded a $1.5 million grant from the National Institutes of Health (NIH) to develop and test a secure, individual medication system for long-term care facilities.  Dr. Alan Jacobs, CEO and founder of PerceptiMed will serve as the principal investor and scientific…

Read more